Differential expression of Toll-like receptors in chronic hyperplastic candidosis

Oral Microbiology and Immunology

Volumn 23, Issue 4, 2008, Pages 299-307

  Ali, A ^a,b,c   Natah, S ^d   Konttinen, Y ^e,f,g  

^a BIOMEDICUM HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

^d UNIVERSITY OF CALGARY   (Canada)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^g COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

Candida albicans; Innate immunity; Leukoplakia; Toll like receptors; Zymosan

Indexed keywords

PARAFFIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

ADULT; AGED; ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALE; MOUTH MUCOSA; NONHUMAN; ORAL BIOPSY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THRUSH;

CANDIDA ALBICANS; CANDIDIASIS, ORAL; CHRONIC DISEASE; EPITHELIUM; HUMANS; HYPERPLASIA; HYPHAE; LEUKOPLAKIA, ORAL; MOUTH MUCOSA; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 6; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS;

EID: 45149126416     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2007.00428.x     Document Type: Article

References (43)

1. Ali A, Rautemaa R, Hietanen J, Jarvensivu A, Richardson M, Konttinen Y. Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis. Oral Microbiol Immunol 2006 : 21 : 223 230.
2. Axell T, Samaranayake LP, Reichart PA, Olsen I. A proposal for reclassification of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 : 84 : 111 112.
3. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977 : 5 : 69 75.
4. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 2004 : 19 : 293 296.
5. Bellocchio S, Moretti S, Perruccio K et al. TLRs govern neutrophil activity in aspergillosis. J Immunol 2004 : 173 : 7406 7415.
6. Cabay RJ, Morton TH Jr., Epstein JB. Proliferative verrucous leukoplakia and its progression to oral carcinoma: a review of the literature. J Oral Pathol Med 2007 : 36 : 255 261.
7. Cannom RR, French SW, Johnston D, Edwards EJ Jr., Filler SG. Candida albicans stimulates local expression of leukocyte adhesion molecules and cytokines in vivo. J Infect Dis 2002 : 186 : 389 396.
8. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000 : 11 : 172 198.
9. Fidel PL Jr. Distinct protective host defenses against oral and vaginal candidiasis. Med Mycol 2002 : 40 : 359 375.
10. Gil ML, Fradelizi D, Gozalbo D. TLR2: for or against Candida albicans? Trends Microbiol 2005 : 13 : 298 299.
11. Gil ML, Gozalbo D. TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect 2006 : 8 : 2299 2304.
12. Han J, Ulevitch RJ. Limiting inflammatory responses during activation of innate immunity. Nat Immunol 2005 : 6 : 1198 1205.
13. Kleinegger CL, Stoeckel DC, Kurago ZB. A comparison of salivary calprotectin levels in subjects with and without oral candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 : 92 : 62 67.
14. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996 : 86 : 973 983.
15. Liew FY, Xu D, Brint EK, O'Neill LA. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005 : 5 : 446 458.
16. Liu L, Kang K, Takahara M, Cooper KD, Ghannoum MA. Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect Immun 2001 : 69 : 4695 4697.
17. Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell 1997 : 90 : 939 949.
18. Mahanonda R, Pichyangkul S. Toll-like receptors and their role in periodontal health and disease. Periodontol 2000 2007 : 43 : 41 55.
19. Malic S, Hill KE, Ralphs JR et al. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy. Oral Microbiol Immunol 2007 : 22 : 188 194.
20. Matthews RC, Burnie JP. Recombinant antibodies: a natural partner in combinatorial antifungal therapy. Vaccine 2004 : 22 : 865 871.
21. McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol 2002 : 38 : 391 393.
22. Netea MG, Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002 : 185 : 1483 1489.
23. Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004 : 172 : 3712 3718.
24. Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 2004 : 12 : 484 488.
25. Netea MG, van der Meer JW, Kullberg BJ. Both TLR2 and TLR4 are involved in the recognition of Candida albicans. Reply to 'TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae' by Gil and Gozalbo, Microb Infect 8 (2006) 2823-2824. Microbes Infect 2006 : 8 : 2821 2822.
26. Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999 : 29 : 253 258.
27. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004 : 12 : 44 49.
28. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol 2004 : 42 : 485 498.
29. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999 : 2 : 363 367.
30. Romani L. Innate and adaptive immunity in Candida albicans infections and saprophytism. J Leukoc Biol 2000 : 68 : 175 179.
31. Romani L, Bistoni F, Puccetti P. Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol 2003 : 6 : 338 343.
32. Rubin RH. Fungal and bacterial infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 1993 : 12 (suppl 1 S42 48.
33. Samaranayake YH, Samaranayake LP. Experimental oral candidiasis in animal models. Clin Microbiol Rev 2001 : 14 : 398 429.
34. Sherwood J, Gow NA, Gooday GW, Gregory DW, Marshall D. Contact sensing in Candida albicans: a possible aid to epithelial penetration. J Med Vet Mycol 1992 : 30 : 461 469.
35. Sobel JD, Myers PG, Kaye D, Levison ME. Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Infect Dis 1981 : 143 : 76 82.
36. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003 : 21 : 335 376.
37. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005 : 17 : 1 14.
38. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007 : 7 : 179 190.
39. Underhill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002 : 14 : 103 110.
40. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 2005 : 73 : 7458 7464.
41. Villar CC, Kashleva H, Dongari-Bagtzoglou A. Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol Immunol 2004 : 19 : 262 269.
42. Williams DW, Bartie KL, Potts AJ, Wilson MJ, Fardy MJ, Lewis MA. Strain persistence of invasive Candida albicans in chronic hyperplastic candidosis that underwent malignant change. Gerodontology 2001 : 18 : 73 78.
43. Xu YY, Samaranayake LP. Oral Candida albicans biotypes in Chinese patients with and without oral candidosis. Arch Oral Biol 1995 : 40 : 577 579.